BACKGROUND: The influence of atrioventricular septal defect (AVSD) subtype on outcomes after repair is poorly understood. METHODS: Demographic, procedural, and outcome data were obtained 1 and 6 months after AVSD repair in an observational study conducted at 7 North American centers. RESULTS: The 215 AVSD patients were subtyped as 60 partial, 27 transitional, 120 complete, and 8 with canal-type VSD. Preoperatively, transitional patients had the highest prevalence of moderate or severe left atrioventricular valve regurgitation (LAVVR, p = 0.01). At repair, complete AVSD and canal-type VSD patients, both with the highest prevalence of trisomy 21 (p < 0.001), were younger (p < 0.001), had lower weight-for-age z scores (p = 0.005), and had more associated cardiac defects (p < 0.001). Annuloplasty was similar among subtypes (p = 0.91), with longer duration of ventilation and hospitalization for complete AVSD (p < 0.001). Independent predictors of moderate or severe LAVVR at the 6-month follow-up were older log(age) at repair (p = 0.02) but not annuloplasty, subtype, or center (p > 0.4). Weight-for-age z scores improved in all subtypes at the 6-month follow-up, and improvement was similar among subtypes (p = 0.17). CONCLUSIONS: AVSD subtype was significantly associated with patient characteristics and clinical status before repair and influenced age at repair. Significant postoperative LAVVR is the most common sequela, with a similar prevalence across centers 6 months after the intervention. Annuloplasty failed to decrease the postoperative prevalence of moderate or severe LAVVR at 6 months. After accounting for age at repair, AVSD subtype was not associated with postoperative LAVVR severity or growth failure at 6 months. Further investigation is needed to determine if interventional strategies specific to AVSD subtype improve surgical outcomes.
RCT Entities:
BACKGROUND: The influence of atrioventricular septal defect (AVSD) subtype on outcomes after repair is poorly understood. METHODS: Demographic, procedural, and outcome data were obtained 1 and 6 months after AVSD repair in an observational study conducted at 7 North American centers. RESULTS: The 215 AVSDpatients were subtyped as 60 partial, 27 transitional, 120 complete, and 8 with canal-type VSD. Preoperatively, transitional patients had the highest prevalence of moderate or severe left atrioventricular valve regurgitation (LAVVR, p = 0.01). At repair, complete AVSD and canal-type VSDpatients, both with the highest prevalence of trisomy 21 (p < 0.001), were younger (p < 0.001), had lower weight-for-age z scores (p = 0.005), and had more associated cardiac defects (p < 0.001). Annuloplasty was similar among subtypes (p = 0.91), with longer duration of ventilation and hospitalization for complete AVSD (p < 0.001). Independent predictors of moderate or severe LAVVR at the 6-month follow-up were older log(age) at repair (p = 0.02) but not annuloplasty, subtype, or center (p > 0.4). Weight-for-age z scores improved in all subtypes at the 6-month follow-up, and improvement was similar among subtypes (p = 0.17). CONCLUSIONS:AVSD subtype was significantly associated with patient characteristics and clinical status before repair and influenced age at repair. Significant postoperative LAVVR is the most common sequela, with a similar prevalence across centers 6 months after the intervention. Annuloplasty failed to decrease the postoperative prevalence of moderate or severe LAVVR at 6 months. After accounting for age at repair, AVSD subtype was not associated with postoperative LAVVR severity or growth failure at 6 months. Further investigation is needed to determine if interventional strategies specific to AVSD subtype improve surgical outcomes.
Authors: Luis Alesandro Larrazabal; Pedro J del Nido; Kathy J Jenkins; Kimberlee Gauvreau; Ronald Lacro; Steve D Colan; Frank Pigula; Oscar J Benavidez; Francis Fynn-Thompson; John E Mayer; Emile A Bacha Journal: Ann Thorac Surg Date: 2007-01 Impact factor: 4.330
Authors: G S Van Arsdell; W G Williams; C Boutin; G A Trusler; J G Coles; I M Rebeyka; R M Freedom Journal: J Thorac Cardiovasc Surg Date: 1995-11 Impact factor: 5.209
Authors: Randall S Fortuna; David A Ashburn; Nilto Carias De Oliveira; Harold M Burkhart; Igor E Konstantinov; John G Coles; Jeffery F Smallhorn; William G Williams; Glen S Van Arsdell Journal: Ann Thorac Surg Date: 2004-03 Impact factor: 4.330
Authors: Muralidhar Padala; Nikolay V Vasilyev; James W Owen; Jorge H Jimenez; Lakshmi P Dasi; Pedro J del Nido; Ajit P Yoganathan Journal: J Thorac Cardiovasc Surg Date: 2008-09-14 Impact factor: 5.209
Authors: L LuAnn Minich; Andrew M Atz; Steven D Colan; Lynn A Sleeper; Seema Mital; James Jaggers; Renee Margossian; Ashwin Prakash; Jennifer S Li; Meryl S Cohen; Ronald V Lacro; Gloria L Klein; John A Hawkins Journal: Ann Thorac Surg Date: 2010-02 Impact factor: 4.330
Authors: James D St Louis; Upinder Jodhka; Jeffrey P Jacobs; Xia He; Kevin D Hill; Sara K Pasquali; Marshall L Jacobs Journal: J Thorac Cardiovasc Surg Date: 2014-07-21 Impact factor: 5.209
Authors: Danielle S Burstein; Patrick E Gray; Heather M Griffis; Andrew C Glatz; Meryl S Cohen; J William Gaynor; David J Goldberg Journal: Pediatr Cardiol Date: 2019-05-07 Impact factor: 1.655